Kernt, Marcus <br/><br/>
Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Sep 2012 
 - 1652-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0b013e318240a558  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--pharmacology<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Benzenesulfonates--pharmacology<br/>Cells, Cultured<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Immunohistochemistry<br/>Indazoles<br/>Light<br/>Middle Aged<br/>Neuropilin-1--genetics<br/>Neuropilin-2--genetics<br/>Neuropilins--genetics<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Platelet-Derived Growth Factor--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyridines--pharmacology<br/>Pyrimidines--pharmacology<br/>RNA, Messenger--metabolism<br/>Ranibizumab<br/>Receptors, Vascular Endothelial Growth Factor--genetics<br/>Retinal Pigment Epithelium--drug effects<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sorafenib<br/>Sulfonamides--pharmacology<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vascular Endothelial Growth Factor Receptor-1--genetics<br/>Vascular Endothelial Growth Factor Receptor-2--genetics